Apheresis in Cellular Therapies: Unlocking Quality for CAR T and Stem Cell Treatments

Discover an informative webinar focusing on the pivotal role of apheresis in sourcing high-quality starting material for cellular therapies.

As the landscape of regenerative medicine continues to evolve, understanding the intricacies of apheresis becomes increasingly vital. In this webinar, the expert presenters will guide you through the apheresis procedure, emphasizing its significance in the collection of cellular components necessary for therapies like CAR T-cell treatments and stem cell transplants, detailing donor sourcing patient treatment considerations.

They will also highlight how apheresis-based bone marrow transplantation and donor programs can enhance or advance hospital programs, bolstering reputation and serving more patients. Moreover, they will cover the critical role that skilled nurses play in ensuring the safety and comfort of both patients and donors during the process and underscore how expertise not only enhances the patient experience but also directly impacts the quality of the collected material.

With a focus on quality, the expert speakers will then describe the impact of adherence to collection protocols and the real-world implications for treatment outcomes. Attendees will learn how subtle differences in the apheresis process can lead to significant discrepancies in the cellular products, ultimately affecting the efficacy of the therapies derived from them.

Finally, they will discuss the importance of selecting qualified practitioners for apheresis procedures and the criteria for evaluating practitioner expertise as well as systems that ensure optimal results.

Register for this webinar today to understand the role of apheresis in sourcing high-quality starting materials for cellular therapies like CAR T-cell treatments and stem cell transplants.

Keywords: Stem Cells, Clinical Trials, Clinical Research, Cell Therapy, Stem Cell Therapy, Cell Therapies, Cell and Gene Therapies, Cell and Gene Therapy, CGT

Others Details

Life Sciences,Clinical Trials,Cell and Gene Therapy